Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancer

Authors:

Abstract
Combination of intravenous (i.v.) vinorelbine and capecitabine was shown to be feasible and effective in metastatic breast cancer (MBC). In an effort to improve patient convenience and to prolong infusion-free survival, we investigated in first-line treatment a regimen combining oral vinorelbine and capecitabine in a phase II study.

This publication has 22 references indexed in Scilit: